Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128628) titled 'Construction and clinical translation of a predictive model for high-risk pathological subtypes and gene mutations in lung adenocarcinoma based on the fusion of artificial intelligence and radiomics features' on July 23.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: The Second Affiliated Hospital of Hainan Medical University
Condition:
Lung adenocarcinoma
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-08-01
Target Sample Size: Modeling team and validation team:800;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.c...